Pyxis Oncology, Inc. · Brief

Next report

2 days

Nov 2 · before openest.Q3 FY26

Expected move

±38.7%implied · straddle

1.112.51

spot 1.81exp Nov 20ATM strike 2ATM straddle 0.83IV 225%

Oct 30 close

Expected move

—≥ implied

Q2 FY26±30.0%▼−5.35%×0.18

quarterimplied−30%0+30%realized×

Q2 FY26±30.0%▼−5.35%×0.18

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Nov 2 report · est.

Bull2 of 3

9disclosed supplier and customer ties in SEC filingsSEC filings

79managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2

10 of 23of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26

9managers whose positions together make up four fifths of the reported value13F · Jun 30 '26

AI captions · Sep 28 '26once per report · top 2 per case

PYXS report session

No linked exposure.

Oct 19impliedImplied move: ±40.3% into Nov 2 earnings (Oct 19 close).Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.